2003
Giemsa
HE HE
AE1+AE3 HBME1
HE HE
Well differentiated adenocarcinoma of colon
Giemsa HE
HE 62 Group V
HE
47 Group V Peritoneal dissemination of gastric cancer
HE 51 Poorly differentiated Adenocarcinoma(por2)
HE
75 Poorly differentiated adenocarcinoma
CEA
CEA CEA ( ) 1. 2,500rpm 2 2. 100% - 2 3. 3%H2O2-30 4. PBS 10 5. 10% 10 6. CEA 1,000 5 7. PBS 5 3 8. 100 5 9. PBS 10 10. DAB 5 11. 12. 5 13. 14. 15. 20
ph7.4 PBS ( 10% : CEDARLANE, CL1500 ) 500 l / 5ml ( CEA 1000 : CEM010 ) 5 l / 5ml ( - Fab AmershamNA9310 ) 50 l / 5ml HE
HE 75 2 Moderately differentiated adenocarcinoma Metastatic moderately differentiated adenocarcinoma
CEA CEA
HE HE
45 3 Lobular carcinoma Metastatic carcinoma,probably due to lobular carcinoma of brest
CEA HE
HE HE
77 male Sentinel lymph-node medullary carcinoma X10 PAP
X40 PAP X10 Giemsa
X40 Giemsa X4 HE
X10 HE 76 female skull tumor 1 Multiple myeloma of skull
x40pap x40giemsa
x40giemsa x4he
X10HE 60 male MK Pheochromocytoma
X10 PAP X40 PAP
X40 PAP X10 Giemsa
X40 Giemsa X4 HE
X10 HE
45 Islet cell tumore
79 TV Squamous cell carcinoma
47
55
43
56,
PAS
0 c,por2,se,p1,stage CY 1 CY0 : CY1 : CYX Suspicious malignancy CY0 CY1 Stage C ( P1CY1 1 C
Stage) N0 N1 N2 N3 T1 IA IB II T2 IB II IIIA T3 II IIIA IIIB T4 IIIA IIIB H1,P1,CY1,M1 54, 13 2 MRI 13 6
: 62, : E E MRI,MMG
( (invasive ductal carcinoma with a predominant intraductal component)